---
figid: PMC7789326__12986_2020_534_Fig4_HTML
figtitle: SHMOs exerting anti-inflammatory effects in NEC
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Escherichia coli
- Armoracia rusticana
- Canis lupus familiaris
- Meleagris gallopavo
organisms_ner:
- Canis lupus familiaris
- Homo sapiens
- Rattus norvegicus
- Mus musculus
pmcid: PMC7789326
filename: 12986_2020_534_Fig4_HTML.jpg
figlink: pmc/articles/PMC7789326/figure/Fig4/
number: F4
caption: Schematic diagram of SHMOs exerting anti-inflammatory effects in NEC. Pooled
  SHMOs mixture attenuated hyper-expressed TLR4, inhibited NF-κB-mediated production
  of inflammatory cytokines, attenuated mitochondrial dysfunction and NLRP3 activation,
  and thereby mitigated inflammatory injury in NEC. The red arrows indicate the change
  of signaling molecules after exposure to SHMOs; the red lines indicate the potential
  steps that SHMOs might affect in the pathway. IκB-α, inhibitor κB-α; IL-1β, interleukin-1β;
  IL-6, interleukin-6; LPS, lipopolysaccharide; NF-κB, nuclear factor-κB; NLRP3, nod-like
  receptor pyrin 3; TNF-α, tumor necrosis factor-α; TLR4, toll like receptor 4
papertitle: Sialylated human milk oligosaccharides prevent intestinal inflammation
  by inhibiting toll like receptor 4/NLRP3 inflammasome pathway in necrotizing enterocolitis
  rats.
reftext: Wenting Zhang, et al. Nutr Metab (Lond). 2021;18:5.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9766228
figid_alias: PMC7789326__F4
figtype: Figure
redirect_from: /figures/PMC7789326__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7789326__12986_2020_534_Fig4_HTML.html
  '@type': Dataset
  description: Schematic diagram of SHMOs exerting anti-inflammatory effects in NEC.
    Pooled SHMOs mixture attenuated hyper-expressed TLR4, inhibited NF-κB-mediated
    production of inflammatory cytokines, attenuated mitochondrial dysfunction and
    NLRP3 activation, and thereby mitigated inflammatory injury in NEC. The red arrows
    indicate the change of signaling molecules after exposure to SHMOs; the red lines
    indicate the potential steps that SHMOs might affect in the pathway. IκB-α, inhibitor
    κB-α; IL-1β, interleukin-1β; IL-6, interleukin-6; LPS, lipopolysaccharide; NF-κB,
    nuclear factor-κB; NLRP3, nod-like receptor pyrin 3; TNF-α, tumor necrosis factor-α;
    TLR4, toll like receptor 4
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TLR4
  - NLRP3
  - IL18
  - IL1B
  - TNF
  - IL6
  - NFKBIA
  - NFKB1
  - Tlr4
  - Nfkb1
  - Nlrp3
  - Il18
  - Il1b
  - Tnf
  - Il6
---
